NCT06472804Recruiting
Insomnia in Patients With Metastatic Lung Cancer
Insomnia in Patients With Metastatic Non Small Cell Lung Cancer
Source: ClinicalTrials.gov · Last updated 4 Feb 2026
Brief summary (registry, in English)
This study evaluates how common insomnia (difficulties with sleep) is in patients with lung cancer that has spread from where it first started (primary site) to other places in the body.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 19 Jun 2024
- Start date
- 19 Jun 2019
- Primary completion date
- Jun 2027
- Lead sponsor
- Mayo Clinic
- Diseases
- Lung cancer
- NCT number
- NCT06472804
What you commit to
- Study type: Observational
- Planned participants: 60
- From 19 Jun 2019 to the primary completion date, Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Subjects will be excluded if they are considered to have advanced terminal cancer, severe depression or other psychiatric disorder or a sleep disorder other than insomnia (sleep apnea, restless leg syndrome, sleep related disorder of breathing), regular use of psychotropic medication other than hypnotics (eg antidepressants) per chart review
Who the study is looking for
- Have a diagnosis of metastatic non small cell lung cancer
- Undergoing 1st, 2nd or 3rd line of treatment or are in maintenance therapy
- Older than 18 years old at the time of diagnosis
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic in Rochester Coordinator of this site? Confirm its status | Rochester | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.